H. Ralph Snodgrass
2016
In 2016, H. Ralph Snodgrass earned a total compensation of $1.3M as President, Chief Scientific Officer at Vistagen Therapeutics, a 69% increase compared to previous year.
Compensation breakdown
| Option Awards | $985,025 |
|---|---|
| Salary | $305,000 |
| Total | $1,290,025 |
Snodgrass received $985K in option awards, accounting for 76% of the total pay in 2016.
Snodgrass also received $305K in salary.
Rankings
In 2016, H. Ralph Snodgrass' compensation ranked 7,012th out of 14,075 executives tracked by ExecPay. In other words, Snodgrass earned more than 50.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,012 out of 14,075 | 50th |
Division Manufacturing | 2,634 out of 5,486 | 52nd |
Major group Chemicals And Allied Products | 859 out of 1,900 | 55th |
Industry group Drugs | 661 out of 1,543 | 57th |
Industry Pharmaceutical Preparations | 525 out of 1,173 | 55th |
Source: SEC filing on August 5, 2016.
Snodgrass' colleagues
We found two more compensation records of executives who worked with H. Ralph Snodgrass at Vistagen Therapeutics in 2016.